Daniel Collins, Author at Market Realist

Disclosure: I am in full compliance with all ethics and other policies for Market Realist research analysts. I am not invested in securities that I cover on Market Realist.

AT&T Stock: Jim Cramer’s Views, Wall Street’s Preference

Tesla Solar: Is the Version 3 Roof Really Superior?

Was Warren Buffett Right Not to Invest in Cannabis?

Oil Prices Outlook: Goldman Sachs Sees a New High

MongoDB Stock Gains 5% after a Strong Third Quarter

S&P 500 Outlook: What Are J.P. Morgan’s Views?

Get Real: Catching a Break before 2020

AutoZone Crushes Q1 Earnings Forecast, Stock Soars 6%

Daniel Collins

Waters Stock Soars after Strong Financial Results

These Cannabis Stocks Rose Yesterday

Cara Therapeutics: Earnings Trends and Recent Developments

Cara Therapeutics: A Financial Overview in January

Cara Therapeutics Has Risen ~18% in January

Johnson & Johnson Releases Its 2018 Results: Revenue Up 6.7%

BC Supreme Court Approves iAnthus and MPX’s Deal

Charlotte’s Web Holdings Stock Has Already Risen ~18% in January

These Three Cannabis Stocks Are in the Green Today